Vien Dong Pharmaceutical Joint Stock Company, commonly known as Vien Dong Pharma, is a prominent player in the pharmaceutical industry, headquartered in Vietnam. Established in 2003, the company has made significant strides in the healthcare sector, focusing on the research, development, and production of high-quality pharmaceutical products. With a strong presence in major operational regions across Vietnam, Vien Dong Pharma offers a diverse range of core products, including prescription medications, over-the-counter drugs, and herbal remedies. Their commitment to innovation and quality sets them apart, ensuring that they meet the evolving needs of healthcare professionals and patients alike. Recognised for their contributions to the industry, Vien Dong Pharma has achieved notable milestones, solidifying its market position as a trusted provider of effective healthcare solutions. Their dedication to excellence continues to drive their growth and reputation within the pharmaceutical landscape.
How does Vien Dong Pharmaceutical Joint Stock Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Vien Dong Pharmaceutical Joint Stock Company's score of 20 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Vien Dong Pharmaceutical Joint Stock Company, headquartered in Vietnam, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Vien Dong may not have established formal commitments to address carbon emissions or climate change initiatives at this time. As the pharmaceutical industry increasingly focuses on sustainability, it is essential for companies like Vien Dong to consider developing and implementing strategies to measure and reduce their carbon footprint in alignment with global climate goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Vien Dong Pharmaceutical Joint Stock Company has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
